Fabio
6.9 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioid antagonist; distribution program, reports. | Department of Health; opioid antagonist distribution program; reports. Directs the Department of Health to maintain a list of agencies and organizations that submit requests for and receive opioid antagonists through its distribution program and requires the Department to submit a quarterly report to the Chairs of the House Committee on Appropriations, the House Committee on Health and Human Services, the Senate Committee on Finance and Appropriations, the Senate Committee on Education and Health, and the chair of the Virginia Opioid Abatement Authority on its distribution of opioid antagonists. The bill requires the Department to submit an annual report to the Joint Commission on Health Care and the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by December 1 of each year estimating the costs of the opioid antagonist distribution program for the following fiscal year using a methodology developed by the Department pursuant to parameters set out in the bill. As introduced, the bill was a recommendation of the Joint Commission on Health Care. | us/states/va | Virginia General Assembly | 2026 | HB 1063 | Virginia HB 1063 (2026) |
|
enacted |
|
3 | 35 | 9 | 2026-01-14 | 2026-04-13 | openstates | ocd-bill/29e7e2a7-7b32-4375-813a-c376fa46a916 | https://lis.virginia.gov/bill-details/20261/HB1063 | 60f360c46c2958a5f9c57b044407b5d21978894dd1dfe20a36a6e54fe63c6e2e | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 1063 (2026) — Opioid antagonist; distribution program, reports.
Department of Health; opioid antagonist distribution program; reports. Directs the Department of Health to maintain a list of agencies and organizations that submit requests for and receive opioid antagonists through its distribution program and requires the Department to submit a quarterly report to the Chairs of the House Committee on Appropriations, the House Committee on Health and Human Services, the Senate Committee on Finance and Appropriations, the Senate Committee on Education and Health, and the chair of the Virginia Opioid Abatement Authority on its distribution of opioid antagonists. The bill requires the Department to submit an annual report to the Joint Commission on Health Care and the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by December 1 of each year estimating the costs of the opioid antagonist distribution program for the following fiscal year using a methodology developed by the Department pursuant to parameters set out in the bill. As introduced, the bill was a recommendation of the Joint Commission on Health Care.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Introduced (filed) — source
- Education and Health Substitute (committee substitute) — source
- Enrolled (enrolled) — source
Votes
- Constitutional reading dispensed (on 2nd reading) — 40–0 (pass) · upper
- H VOTE: — 96–0 (pass) · lower
- Subcommittee recommends reporting — 8–0 (pass) · lower
- Reported from Education and Health with substitute — 15–0 (pass) · upper
- H VOTE: — 97–0 (pass) · lower
- Reported from Health and Human Services — 22–0 (pass) · lower
- Passage R — 40–0 (pass) · upper
- Reported from Finance and Appropriations — 14–0 (pass) · upper
- H VOTE: — 95–1 (pass) · lower
Sponsors
- M. Keith Hodges — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2026-01-14 Prefiled and ordered printed; Offered 01-14-2026 26103580D
filing, introduction - 2026-01-14 Referred to Committee on Health and Human Services
referral-committee - 2026-01-19 Fiscal Impact Statement from Department of Planning and Budget (HB1063)
- 2026-01-23 Assigned sub: Behavioral Health
referral-committee - 2026-02-05 Subcommittee recommends reporting (8-Y 0-N)
- 2026-02-10 Reported from Health and Human Services (22-Y 0-N)
committee-passage - 2026-02-12 Read first time
reading-1 - 2026-02-13 Read second time and engrossed
reading-2 - 2026-02-16 Read third time and passed House (96-Y 0-N 0-A)
passage, reading-3 - 2026-02-16 Reconsideration of passage agreed to by House
- 2026-02-16 Passed House (97-Y 0-N 0-A)
passage - 2026-02-17 Constitutional reading dispensed (on 1st reading)
- 2026-02-17 Referred to Committee on Education and Health
referral-committee - 2026-02-24 Assigned Education sub: Health
referral-committee - 2026-02-26 Reported from Education and Health with substitute and rereferred to Finance and Appropriations (15-Y 0-N)
committee-passage - 2026-02-26 Senate committee offered
- 2026-02-27 Committee substitute printed 26108700D-S1
substitution - 2026-02-27 Fiscal Impact Statement from Department of Planning and Budget (HB1063)
- 2026-03-03 Reported from Finance and Appropriations (14-Y 0-N)
committee-passage - 2026-03-03 Rules suspended
- 2026-03-03 Constitutional reading dispensed (on 2nd reading) (40-Y 0-N 0-A)
- 2026-03-03 Passed by for the day (Voice Vote)
- 2026-03-04 Read third time
reading-3 - 2026-03-04 Education and Health Substitute agreed to
- 2026-03-04 Engrossed by Senate - committee substitute
substitution - 2026-03-04 Passed Senate with substitute Block Vote (40-Y 0-N 0-A)
passage - 2026-03-06 Senate substitute agreed to by House (95-Y 1-N 0-A)
substitution - 2026-03-13 Enrolled
enrolled - 2026-03-13 Bill text as passed House and Senate (HB1063ER)
passage - 2026-03-13 Fiscal Impact Statement from Department of Planning and Budget (HB1063)
- 2026-03-13 Signed by Speaker
passage - 2026-03-13 Signed by President
passage - 2026-03-14 Enrolled Bill communicated to Governor on March 14, 2026
enrolled, executive-receipt - 2026-03-14 Governor's Action Deadline 11:59 p.m., April 13, 2026
executive-receipt - 2026-04-13 Approved by Governor-Chapter 729 (effective 7/1/2026)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/29e7e2a7-7b32-4375-813a-c376fa46a916. Confidence: reported (aggregated from official Virginia legislature records).